SREBF1 and metabolic dysfunction-associated steatotic liver disease: Probiotics can alleviate MASLD progression by activating the AMPK pathway to phosphorylate ACC, blocking the SREBP-1/Fas signaling pathway, inhibiting lipogenesis, and increasing fatty acid oxidation [127,128,129,130].